The Library
Cost effectiveness of HPV Vaccination : a systematic review of modelling approaches
Tools
Tools
Tools
Pink, Joshua, Parker, Benjamin A. and Petrou, Stavros (2016) Cost effectiveness of HPV Vaccination : a systematic review of modelling approaches. PharmacoEconomics, 34 (9). pp. 847-861. doi:10.1007/s40273-016-0407-y
![[img]](http://wrap.warwick.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
WRAP_pharmacoeconomicshpvmodelling.pdf - Accepted Version - Requires a PDF viewer. Download (956Kb) |
Official URL: http://dx.doi.org/10.1007/s40273-016-0407-y
Abstract
Background
A large number of economic evaluations have been published that assess alternative possible human papillomavirus (HPV) vaccination strategies. Understanding differences in the modelling methodologies used in these studies is important to assess the accuracy, comparability and generalisability of their results.
Objectives
The aim of this review was to identify published economic models of HPV vaccination programmes and understand how characteristics of these studies vary by geographical area, date of publication and the policy question being addressed.
Methods
We performed literature searches in MEDLINE, Embase, Econlit, The Health Economic Evaluations Database (HEED) and The National Health Service Economic Evaluation Database (NHS EED). From the 1189 unique studies retrieved, 65 studies were included for data extraction based on a priori eligibility criteria. Two authors independently reviewed these articles to determine eligibility for the final review. Data were extracted from the selected studies, focussing on six key structural or methodological themes covering different aspects of the model(s) used that may influence cost-effectiveness results.
Results
More recently published studies tend to model a larger number of HPV strains, and include a larger number of HPV-associated diseases. Studies published in Europe and North America also tend to include a larger number of diseases and are more likely to incorporate the impact of herd immunity and to use more realistic assumptions around vaccine efficacy and coverage. Studies based on previous models often do not include sufficiently robust justifications as to the applicability of the adapted model to the new context.
Conclusions
The considerable between-study heterogeneity in economic evaluations of HPV vaccination programmes makes comparisons between studies difficult, as observed differences in cost effectiveness may be driven by differences in methodology as well as by variations in funding and delivery models and estimates of model parameters. Studies should consistently report not only all simplifying assumptions made but also the estimated impact of these assumptions on the cost-effectiveness results.
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QR Microbiology > QR355 Virology R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
||||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences > Clinical Trials Unit Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School |
||||||
| Library of Congress Subject Headings (LCSH): | Papillomaviruses -- Vaccination -- Cost effectiveness, Papillomaviruses -- Treatment -- Cost effectiveness, Systematic reviews (Medical research) | ||||||
| Journal or Publication Title: | PharmacoEconomics | ||||||
| Publisher: | Adis International Ltd. | ||||||
| ISSN: | 1170-7690 | ||||||
| Official Date: | September 2016 | ||||||
| Dates: |
|
||||||
| Volume: | 34 | ||||||
| Number: | 9 | ||||||
| Page Range: | pp. 847-861 | ||||||
| DOI: | 10.1007/s40273-016-0407-y | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | Published | ||||||
| Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
